StonvexLoading…
StonvexStonvexStonvexCore line items from BBY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $41.69B | $27.88B | $18.20B | $8.77B |
Operating Income | $1.39B | $668.00M | $470.00M | $219.00M |
Net Income | $1.07B | $528.00M | $388.00M | $202.00M |
EPS (Diluted) | $5.04 | $2.48 | $1.82 | $0.95 |
Total Assets | $14.67B | $16.79B | $15.25B | $14.13B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.74B | $923.00M | $1.46B | $1.15B |
Free Cash Flow OCF − CapEx | $1.26B | $155.00M | $442.00M | $-132.00M |
Shares Outstanding | 209.10M | 210.00M | 210.40M | 211.30M |